World Health Organisation (WHO) has recommended two new drugs for COVID-19, providing yet more options for treating the disease. The first drug, Baricitinib, is strongly recommended for patients with severe or critical COVID-19. Baricitinib is an oral drug, used in the treatment of rheumatoid arthritis. WHO has also conditionally recommended the use of a monoclonal antibody drug, Sotrovimab, for treating mild or moderate COVID-19 in patients who are at high risk of hospitalization.
— World Health Organization (WHO) (@WHO) January 14, 2022
(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)